R&D Lab IT Analyst (Contractor) at Legend Biotech

Philadelphia, Pennsylvania, United States

Legend Biotech Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • BS degree with 2 years experience in Biotech/Pharmaceutical industry
  • An understanding of laboratory science in the life sciences industry, preferably in cell therapy space
  • Installing, configuring and supporting systems and applications in lab environments
  • Demonstrate an understanding of the need for standards yet also have a willingness to look for new, more effective strategies to support and improve the laboratory computing environment
  • Experience supporting standalone or enterprise computerized systems and/or applications
  • Commitment to Quality
  • Problem solving skills
  • Ability to work on multiple complex tasks

Responsibilities

  • Provide support and systems management to the lab computing environment in accordance with IT Policies and Procedures
  • Collaborate with scientists, vendors, and IT colleagues on new systems implementation, integration and administration
  • Participate in the installation, documentation, and testing of instrument systems
  • Assist in implementation of data management tools for backup and archive of instrument data
  • Aid in troubleshooting and assist in technical support of both instrument software installed on lab computers and connectivity between computer and instrument
  • Provide user support on scientific software (e.g., LabVantage LIMS, Flow Jo, Zageno, SnapGene, OMIQ, EndNote, BioRender, Journal Subscriptions, etc.)
  • Contribute to development of SOP or Work Instructions for the area
  • Coordinate the necessary risk assessment and qualification protocols to support the GxP applicability of the instrument system (as applicable)
  • Coordinate with engineering, facilities, and quality teams to ensure the timely installation, commissioning, and qualification of laboratory instruments and IT systems
  • Assist in updating any knowledge base articles

Skills

IT Support
Lab IT
R&D Systems
Instrument Onboarding
Network Configuration
GxP
Risk Assessment
Systems Management
Vendor Management

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters
2014Year Founded
$146.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Sick Leave
Paid Holidays
Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI